A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
NCT07343089 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-01-15
Summary
Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.
Conditions
- Borrelia Infections
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-29
- Primary Completion
- 2026-08-31
- Completion
- 2026-08-29
Countries
- France
Study Locations
More Related Trials
-
Impact on the Quality of Life and Persistent Symptoms of Patients Away From Diagnosed and Treated Neuroborreliosis
NCT05742139 ·Status: COMPLETED
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato
NCT06835075 ·Status: ACTIVE_NOT_RECRUITING
-
Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents
NCT05678478 ·Status: COMPLETED
-
Phase 1/2 Lyme Vaccine Study
NCT01504347 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
NCT00028080 ·Status: RECRUITING
-
BOrrelia BUrgdorferi IN Children and Adolescents
NCT05856812 ·Status: COMPLETED
-
Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis
NCT01205464 ·Status: COMPLETED ·Phase: NA
-
Searching for Persistence of Infection in Lyme Disease
NCT01143558 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
NCT02553473 ·Status: COMPLETED ·Phase: PHASE3
-
Risk of Exposure and Prevention of Ticks and Tick-borne Diseases Among Foresters in Alsace
NCT06492668 ·Status: RECRUITING
-
64Cu-DOTATATE-PET for Lyme Neuroborreliosis
NCT06392815 ·Status: RECRUITING ·Phase: NA
-
Understanding Tick-borne Diseases
NCT03501407 ·Status: UNKNOWN
-
Human Anaplasmosis in Eastern France
NCT01013636 ·Status: UNKNOWN
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
NCT02741609 ·Status: TERMINATED ·Phase: NA
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
Characteristics of Lyme Arthritis
NCT03510507 ·Status: UNKNOWN
-
Inflammatory Responses in Solitary and Multiple Erythema Migrans
NCT03980015 ·Status: COMPLETED
-
Study on Early Lyme Neuroborreliosis
NCT00910533 ·Status: UNKNOWN ·Phase: NA
-
Persistent Lyme Empiric Antibiotic Study Europe
NCT01207739 ·Status: COMPLETED ·Phase: PHASE4
-
Place of Intrathecal CXCL-13 in the Diagnosis of Lyme Neuroborreliosis
NCT05625100 ·Status: UNKNOWN
-
Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis
NCT03873974 ·Status: COMPLETED
-
Borrelia B-cell Diagnostics
NCT06045416 ·Status: RECRUITING
-
Human Babesiosis in Metropolitan France
NCT07345988 ·Status: RECRUITING